| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ea50dfca0accdb1ff46b9aac70ed3ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d432dc84370faacba995d9b27a6c63b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89797c06f9003ac011311c4d08389b40 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1354ff1752624dedd27ad673e848157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1203f13dd8a352369c1c7667e6d6952b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c69e4690395cf032a50a1cbb3e7435e7 |
| publicationDate |
2006-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006183702-A1 |
| titleOfInvention |
Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics |
| abstract |
The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015351782-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8105813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9028816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10112989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007117112-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010330084-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010120024-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203766-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014044710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006149041-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011158996-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007172432-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034755-B2 |
| priorityDate |
2004-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |